XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Note 14 - Disclosure of Financial Instruments Not Reported at Fair Value
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

(14)

Disclosure of Financial Instruments Not Reported at Fair Value

 

GAAP requires disclosure of the fair value of financial assets and liabilities, including those financial assets and financial liabilities that are not measured and reported at fair value on a recurring basis or nonrecurring basis. The estimated fair values of Bancorp’s financial instruments not measured at fair value on a recurring or non-recurring basis follows:

 

   

Carrying

           

Fair Value Measurements Using:

 

September 30, 2024 (in thousands)

 

amount

   

Fair value

   

Level 1

   

Level 2

   

Level 3

 
                                         

Assets

                                       

Cash and cash equivalents

  $ 253,066     $ 253,066     $ 253,066     $     $  

HTM debt securities

    374,912       352,430       152,153       200,277        

Federal Home Loan Bank stock

    29,419       29,419             29,419        

Loans, net

    6,192,790       5,962,345                   5,962,345  

Accrued interest receivable

    26,439       26,439       26,439              
                                         

Liabilities

                                       

Non-interest bearing deposits

  $ 1,508,203     $ 1,508,203     $ 1,508,203     $     $  

Transaction deposits

    4,041,448       4,041,448             4,041,448        

Time deposits

    1,176,422       1,174,740             1,174,740        

Securities sold under agreement to repurchase

    149,852       149,852             149,852        

Federal funds purchased

    6,442       6,442             6,442        

Subordinated debentures

    26,806       26,290             26,290        

FHLB advances

    325,000       319,230             319,230        

Accrued interest payable

    2,036       2,036       2,036              

 

   

Carrying

           

Fair Value Measurements Using:

 

December 31, 2023 (in thousands)

 

amount

   

Fair value

   

Level 1

   

Level 2

   

Level 3

 
                                         

Assets

                                       

Cash and cash equivalents

  $ 265,959     $ 265,959     $ 265,959     $     $  

HTM debt securities

    439,837       408,519       198,327       210,192        

Federal Home Loan Bank stock

    16,236       16,236             16,236        

Loans, net

    5,691,664       5,520,059                   5,520,059  

Accrued interest receivable

    26,830       26,830       26,830              
                                         

Liabilities

                                       

Non-interest bearing deposits

  $ 1,548,624     $ 1,548,624     $ 1,548,624     $     $  

Transaction deposits

    4,138,847       4,138,847             4,138,847        

Time deposits

    983,277       976,841             976,841        

Securities sold under agreement to repurchase

    152,991       152,991             152,991        

Federal funds purchased

    12,852       12,852             12,852        

Subordinated debentures

    26,740       26,746             26,746        

FHLB advances

    200,000       200,047             200,047        

Accrued interest payable

    2,094       2,094       2,094              

 

Fair value estimates are made at a specific point in time based on relevant market information and information about financial instruments. Because no market exists for a significant portion of Bancorp’s financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Therefore, calculated fair value estimates in many instances cannot be substantiated by comparison to independent markets and, in many cases, may not be realizable in a current sale of the instrument. Changes in assumptions could significantly impact estimates.